Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held on Tuesday, February 10, 2026, at 11.00 A.M. IST to discuss operational and financial performance of the Company for the quarter and nine months ended December 31, 2025. The invite giving requisite details including the pre-registration link and dial-in details is enclosed herewith. The investor presentation shall be shared with the Exchanges separately.Kindly take the information on record.
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supriya Lifescience has informed the exchanges that it will host an earnings call on Tuesday, February 10, 2026, at 11:00 AM IST. The call will cover the company's operational and financial performance for the quarter and nine months ended December 31, 2025 (Q3 FY26). The invite includes a pre-registration link and dial-in details for participants. An investor presentation will be shared with the exchanges separately before or during the call.
This is a routine pre-results disclosure and does not by itself move the stock. Investors should watch the call for management commentary on revenue growth, margins, and guidance, which could shape sentiment around the Q3 FY26 results.